EUVIMEDEUVIMED entdecken
Open Access

Analysis and therapeutic targeting of the IL-1R pathway in anaplastic large cell lymphoma

Zhihui Song, Wenjun Wu, Wei Wei iD, Wenming Xiao, Michelle Lei, Kathy Q Cai iD, Da Wei Huang, Subin Jeong iD, Jing-Ping Zhang, Hongbo Wang, Marshall E Kadin iD, Thomas A Waldmann und 3 weitere

Blood · 2023

DOI: 10.1182/blood.2022019166 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Blood, 2023. Verfasst von Zhihui Song und 14 weiteren Autor:innen. Beteiligte Einrichtung: Blood Cell Development and Function Program, Fox Chase Cancer Center, Philadelphia, PA. Hauptthemen laut MEDLINE: Lymphoma, Large-Cell, Anaplastic, Lymphoma, Primary Cutaneous Anaplastic Large Cell, Skin Neoplasms. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Anaplastic large cell lymphoma (ALCL), a subgroup of mature T-cell neoplasms with an aggressive clinical course, is characterized by elevated expression of CD30 and anaplastic cytology. To achieve a comprehensive understanding of the molecular characteristics of ALCL pathology and to identify therapeutic vulnerabilities, we applied genome-wide CRISPR library screenings to both anaplastic lymphoma kinase positive (ALK+) and primary cutaneous (pC) ALK− ALCLs and identified an unexpected role of the interleukin-1R (IL-1R) inflammatory pathway in supporting the viability of pC ALK− ALCL. Importantly, this pathway is activated by IL-1α in an autocrine manner, which is essential for the induction and maintenance of protumorigenic inflammatory responses in pC-ALCL cell lines and primary cases. Hyperactivation of the IL-1R pathway is promoted by the A20 loss-of-function mutation in the pC-ALCL lines we analyze and is regulated by the nonproteolytic protein ubiquitination network. Furthermore, the IL-1R pathway promotes JAK-STAT3 signaling activation in ALCLs lacking STAT3 gain-of-function mutation or ALK translocation and enhances the sensitivity of JAK inhibitors in these tumors in vitro and in vivo. Finally, the JAK2/IRAK1 dual inhibitor, pacritinib, exhibited strong activities against pC ALK− ALCL, where the IL-1R pathway is hyperactivated in the cell line and xenograft mouse model. Thus, our studies revealed critical insights into the essential roles of the IL-1R pathway in pC-ALCL and provided opportunities for developing novel therapeutic strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lymphoma, Large-Cell, AnaplasticLymphoma, Primary Cutaneous Anaplastic Large CellSkin NeoplasmsHumansAnimalsMiceReceptor Protein-Tyrosine KinasesAnaplastic Lymphoma KinaseInterleukins

Substanzen

Receptor Protein-Tyrosine KinasesAnaplastic Lymphoma KinaseInterleukins

Autor:innen und Institutionen

  • Blood Cell Development and Function Program, Fox Chase Cancer Center, Philadelphia, PA.
  • Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD.
  • Histopathology Facility, Fox Chase Cancer Center, Philadelphia, PA.
  • Lymphoid Malignancies Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD.
  • Department of Pathology and Laboratory Medicine, Brown University Alpert School of Medicine, Providence, RI.
  • Department of Hematology, Hokkaido University Faculty of Medicine, Sapporo, Japan.

ORCID-Profile: Wei Wei, Kathy Q Cai, Subin Jeong, Marshall E Kadin, Masao Nakagawa, Yibin Yang

Förderung

  • NCI NIH HHS

Zitieren

APA

Song, Z., Wu, W., Wei, W., Xiao, W., Lei, M., Cai, K. Q., Huang, D. W., Jeong, S., Zhang, J. P., Wang, H., Kadin, M. E., Waldmann, T. A., Staudt, L. M., Nakagawa, M., & Yang, Y. (2023). Analysis and therapeutic targeting of the IL-1R pathway in anaplastic large cell lymphoma. Blood. https://doi.org/10.1182/blood.2022019166

Vancouver

Song Z, Wu W, Wei W, Xiao W, Lei M, Cai KQ, et al. Analysis and therapeutic targeting of the IL-1R pathway in anaplastic large cell lymphoma. Blood. 2023. doi:10.1182/blood.2022019166

BibTeX
@article{Song2023,
  author = {Song, Zhihui and Wu, Wenjun and Wei, Wei and Xiao, Wenming and Lei, Michelle and Cai, Kathy Q and Huang, Da Wei and Jeong, Subin and Zhang, Jing-Ping and Wang, Hongbo and Kadin, Marshall E and Waldmann, Thomas A and Staudt, Louis M and Nakagawa, Masao and Yang, Yibin},
  title = {Analysis and therapeutic targeting of the IL-1R pathway in anaplastic large cell lymphoma},
  journal = {Blood},
  year = {2023},
  doi = {10.1182/blood.2022019166}
}
Kostenlos starten →